• Cy5.5 NHS ester Workflows for Hydrogel Imaging

  2026-09-10

  Build a practical labeling and imaging workflow around Cy5.5 NHS ester (non-sulfonated) to quantify biomolecule retention, hydrogel localization, and delivery performance. The approach connects near-infrared fluorescence imaging with the bioadhesive miR-140 hydrogel strategy reported in aged osteoarthritis research, while addressing solvent, purification, and signal-interpretation risks.

• GW4064, FXR Signaling, and NiONP-Induced Fibrosis

  2026-09-10

  The reference study identifies hsa_circ_0001944 as a regulatory node connecting FXR, TLR4, ferroptosis, and collagen deposition in nickel oxide nanoparticle-exposed hepatic stellate cells. Its use of GW4064 alongside pathway inhibitors, a ferroptosis inducer, and circRNA overexpression provides pharmacological and molecular evidence that FXR activation may restrain toxicant-associated fibrogenic responses.

• Palomid 529 (P529) for ESCC Research

  2026-09-09

  Palomid 529 (P529) gives researchers a practical way to interrogate PI3K/Akt/mTOR signaling in esophageal squamous cell carcinoma, including cisplatin resistance, metastasis, angiogenesis, and radiotherapy response. Its dual mTORC1/mTORC2 activity also supports mechanism-focused combination assays when paired with genetic controls and carefully optimized exposure conditions.

• Erlotinib Workflows for EGFR Research

  2026-09-09

  Erlotinib, also known as NSC 718781, provides a practical way to quantify EGFR kinase suppression in biochemical and cell-based cancer models. This guide connects reproducible EGFR assays with SCUBE3-driven resistance biology, offering workflow parameters, assay-selection guidance, and troubleshooting strategies.

• MK-571: Linking Leukotriene Signaling to Drug Resistance

  2026-09-08

  MK-571 (L-660,711) is best understood not only as a cysteinyl leukotriene receptor antagonist, but also as a strategic probe for separating airway inflammation from transporter and redox biology. This article connects its established cysLT1 pharmacology with recent macrophage findings involving system Xc−, glutathione, and ABCC1, while outlining validation strategies that reduce interpretive ambiguity in translational studies.

• DIDS: A Mechanism-Aware Research Guide

  2026-09-08

  DIDS is more than a chloride channel blocker: its value depends on separating ion-transport pharmacology from context-dependent cell-death biology. This guide translates DIDS data into practical assay decisions, with special attention to metastasis models, TRPV1 channel modulation, vascular studies, and experimental controls.

• NHE1, Olfr2, and Calcium-Driven Atherosclerosis

  2026-09-07

  This Scientific Reports study identifies macrophage NHE1 as a downstream effector of octanal–Olfr2 signaling in atherosclerosis, linking calcium-dependent oxidative stress with NLRP3-associated inflammation. By combining ApoE−/− mice, RAW264.7 macrophages, pharmacological inhibition, RNA interference, and calcium chelation, the work strengthens a mechanistic model in which NHE1 contributes to plaque formation and inflammatory activation.

• EGF-Driven Migration Without EMT in A549 Cells

  2026-09-07

  The reference study separates epidermal growth factor-driven migration from epithelial–mesenchymal transition and invasion in A549 lung adenocarcinoma cells. Its combined imaging, pathway, transcript, protein, and proteomic analyses show that EGF and TGFβ can produce similar motility while relying on different kinetics and molecular programs.

• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-09-05

  The reference study establishes a streamlined 3D culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. These organoids can be cryopreserved, differentiated into intestinal epithelial cells, and evaluated for transporter and cytochrome P450 activities relevant to human pharmacokinetic studies.

• DAPI Nuclear Stain Solution: Practical Guide

  2026-09-04

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution, SKU K2402, provides a ready-to-use fluorescent DNA binding dye for nuclear visualization and endpoint assessment of membrane integrity. It is intended for fixed or membrane-compromised samples analyzed by fluorescence microscopy or flow cytometry, not routine imaging of intact live cells.

• LLY-507: A Translational Lens on SMYD2 Biology

  2026-09-04

  LLY-507 offers a selective way to interrogate SMYD2-driven methylation, cancer cell proliferation, and fibrosis-related signaling. This thought-leadership guide connects biochemical potency with assay strategy, biomarker development, and the translational limits that researchers should address before moving toward therapeutic hypotheses.

• VX-765 Workflows for Caspase-1 Research

  2026-09-03

  VX-765 enables mechanism-focused studies of caspase-1, cytokine maturation, and pyroptotic cell death. This practical guide connects biochemical assays with macrophage, rheumatoid arthritis, and HIV-associated CD4 T-cell workflows while highlighting the compound’s important caspase-8 selectivity caveat.

• Nadolol (SQ-11725) Research Workflow Guide

  2026-09-03

  Nadolol (SQ-11725) combines reproducible non-selective beta-adrenergic blockade with transporter-focused pharmacokinetic opportunities for cardiovascular models. This practical guide adapts an integrated distribution-and-metabolism framework to hypertension research, angina pectoris studies, and vascular headache research while clearly separating established product properties from proposed assay conditions.

• TRIB3, Ferroptosis, and Sunitinib Sensitivity in ccRCC

  2026-09-02

  The reference study identifies TRIB3 knockdown as a way to increase sunitinib sensitivity in clear cell renal cell carcinoma by promoting ferroptosis through the SLC7A11/GPX4 pathway. Its combination of bioinformatics, gene silencing, drug-response testing, and ferroptosis validation provides a mechanistic framework for studying therapy resistance in ccRCC.

• DIDS: Reliable Chloride-Channel Assay Design

  2026-09-02

  Learn how DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid), SKU B7675, can improve mechanistic interpretation in cell viability, cytotoxicity, and ion-transport experiments. This scenario-based guide covers assay compatibility, preparation, quantitative benchmarks, and practical vendor-selection criteria.

8579 records 4/572 page Previous Next 12345 下5页 Last page